334 related articles for article (PubMed ID: 27153057)
1. γ-Tocotrienol as a Promising Countermeasure for Acute Radiation Syndrome: Current Status.
Singh VK; Hauer-Jensen M
Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27153057
[TBL] [Abstract][Full Text] [Related]
2. Radioprotective Efficacy of Gamma-Tocotrienol in Nonhuman Primates.
Singh VK; Kulkarni S; Fatanmi OO; Wise SY; Newman VL; Romaine PL; Hendrickson H; Gulani J; Ghosh SP; Kumar KS; Hauer-Jensen M
Radiat Res; 2016 Mar; 185(3):285-98. PubMed ID: 26930378
[TBL] [Abstract][Full Text] [Related]
3. Effects of Gamma-Tocotrienol on Intestinal Injury in a GI-Specific Acute Radiation Syndrome Model in Nonhuman Primate.
Garg S; Garg TK; Wise SY; Fatanmi OO; Miousse IR; Savenka AV; Basnakian AG; Singh VK; Hauer-Jensen M
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563033
[TBL] [Abstract][Full Text] [Related]
4. A Metabolomic Serum Signature from Nonhuman Primates Treated with a Radiation Countermeasure, Gamma-tocotrienol, and Exposed to Ionizing Radiation.
Pannkuk EL; Laiakis EC; Fornace AJ; Fatanmi OO; Singh VK
Health Phys; 2018 Jul; 115(1):3-11. PubMed ID: 29787425
[TBL] [Abstract][Full Text] [Related]
5. A Metabolomic and Lipidomic Serum Signature from Nonhuman Primates Administered with a Promising Radiation Countermeasure, Gamma-Tocotrienol.
Cheema AK; Mehta KY; Fatanmi OO; Wise SY; Hinzman CP; Wolff J; Singh VK
Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29283379
[TBL] [Abstract][Full Text] [Related]
6. Development of gamma-tocotrienol as a radiation medical countermeasure for the acute radiation syndrome: current status and future perspectives.
Singh VK; Seed TM
Expert Opin Investig Drugs; 2023 Jan; 32(1):25-35. PubMed ID: 36655861
[TBL] [Abstract][Full Text] [Related]
7. Granulocyte colony-stimulating factor antibody abrogates radioprotective efficacy of gamma-tocotrienol, a promising radiation countermeasure.
Kulkarni S; Singh PK; Ghosh SP; Posarac A; Singh VK
Cytokine; 2013 May; 62(2):278-85. PubMed ID: 23561424
[TBL] [Abstract][Full Text] [Related]
8. Pathology of acute sub-lethal or near-lethal irradiation of nonhuman primates prophylaxed with the nutraceutical, gamma tocotrienol.
Singh VK; Wise SY; Fatanmi OO; Petrus SA; Carpenter AD; Lugo-Roman LA; Lee SH; Hauer-Jensen M; Seed TM
Sci Rep; 2024 Jun; 14(1):13315. PubMed ID: 38858439
[TBL] [Abstract][Full Text] [Related]
9. Progenitor Cell Mobilization by Gamma-tocotrienol: A Promising Radiation Countermeasure.
Singh VK; Fatanmi OO; Verma A; Newman VL; Wise SY; Romaine PL; Berg AN
Health Phys; 2016 Aug; 111(2):85-92. PubMed ID: 27356050
[TBL] [Abstract][Full Text] [Related]
10. Gamma-tocotrienol, a radiation countermeasure, reverses proteomic changes in serum following total-body gamma irradiation in mice.
Rosen E; Fatanmi OO; Wise SY; Rao VA; Singh VK
Sci Rep; 2022 Mar; 12(1):3387. PubMed ID: 35233005
[TBL] [Abstract][Full Text] [Related]
11. Gamma-tocotrienol, a radiation prophylaxis agent, induces high levels of granulocyte colony-stimulating factor.
Kulkarni SS; Cary LH; Gambles K; Hauer-Jensen M; Kumar KS; Ghosh SP
Int Immunopharmacol; 2012 Dec; 14(4):495-503. PubMed ID: 23000517
[TBL] [Abstract][Full Text] [Related]
12. Development of Orally Administered γ-Tocotrienol (GT3) Nanoemulsion for Radioprotection.
Ledet GA; Biswas S; Kumar VP; Graves RA; Mitchner DM; Parker TM; Bostanian LA; Ghosh SP; Mandal TK
Int J Mol Sci; 2016 Dec; 18(1):. PubMed ID: 28029115
[TBL] [Abstract][Full Text] [Related]
13. THE POTENTIATION OF THE RADIOPROTECTIVE EFFICACY OF TWO MEDICAL COUNTERMEASURES, GAMMA-TOCOTRIENOL AND AMIFOSTINE, BY A COMBINATION PROPHYLACTIC MODALITY.
Singh VK; Fatanmi OO; Wise SY; Newman VL; Romaine PL; Seed TM
Radiat Prot Dosimetry; 2016 Dec; 172(1-3):302-310. PubMed ID: 27542813
[TBL] [Abstract][Full Text] [Related]
14. γ-Tocotrienol-Loaded Liposomes for Radioprotection from Hematopoietic Side Effects Caused by Radiotherapeutic Drugs.
Lee SG; Kalidindi TM; Lou H; Gangangari K; Punzalan B; Bitton A; Lee CJ; Vargas HA; Park S; Bodei L; Kharas MG; Singh VK; Kishore Pillarsetty NV; Larson SM
J Nucl Med; 2021 Apr; 62(4):584-590. PubMed ID: 32826318
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of Neulasta or Neupogen on H-ARS and GI-ARS Mortality and Hematopoietic Recovery in Nonhuman Primates After 10-Gy Irradiation With 2.5% Bone Marrow Sparing.
Farese AM; Bennett AW; Gibbs AM; Hankey KG; Prado K; Jackson W; MacVittie TJ
Health Phys; 2019 Mar; 116(3):339-353. PubMed ID: 30281533
[TBL] [Abstract][Full Text] [Related]
16. Histopathological studies of nonhuman primates exposed to supralethal doses of total- or partial-body radiation: influence of a medical countermeasure, gamma-tocotrienol.
Singh VK; Wise SY; Fatanmi OO; Petrus SA; Carpenter AD; Lee SH; Hauer-Jensen M; Seed TM
Sci Rep; 2024 Mar; 14(1):5757. PubMed ID: 38459144
[TBL] [Abstract][Full Text] [Related]
17. Gamma-Tocotrienol Modulates Total-Body Irradiation-Induced Hematopoietic Injury in a Nonhuman Primate Model.
Garg TK; Garg S; Miousse IR; Wise SY; Carpenter AD; Fatanmi OO; van Rhee F; Singh VK; Hauer-Jensen M
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555814
[TBL] [Abstract][Full Text] [Related]
18. Gamma-tocotrienol, a tocol antioxidant as a potent radioprotector.
Ghosh SP; Kulkarni S; Hieber K; Toles R; Romanyukha L; Kao TC; Hauer-Jensen M; Kumar KS
Int J Radiat Biol; 2009 Jul; 85(7):598-606. PubMed ID: 19557601
[TBL] [Abstract][Full Text] [Related]
19. The Effect of Radiation Dose and Variation in Neupogen® Initiation Schedule on the Mitigation of Myelosuppression during the Concomitant GI-ARS and H-ARS in a Nonhuman Primate Model of High-dose Exposure with Marrow Sparing.
MacVittie TJ; Bennett AW; Farese AM; Taylor-Howell C; Smith CP; Gibbs AM; Prado K; Jackson W
Health Phys; 2015 Nov; 109(5):427-39. PubMed ID: 26425903
[TBL] [Abstract][Full Text] [Related]
20. Gamma tocotrienol, a potent radioprotector, preferentially upregulates expression of anti-apoptotic genes to promote intestinal cell survival.
Suman S; Datta K; Chakraborty K; Kulkarni SS; Doiron K; Fornace AJ; Sree Kumar K; Hauer-Jensen M; Ghosh SP
Food Chem Toxicol; 2013 Oct; 60():488-96. PubMed ID: 23941772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
